Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

In a significant medical breakthrough, researchers from King’s College London have found that semaglutide, a drug commonly ...

A recent study reveals that semaglutide, a diabetes medication known for its weight-loss effects, shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a common liver ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.